Suppr超能文献

终末期肾病患者院内心肺脑复苏后的发病率和存活率:一项全国范围内基于人群的研究。

The incidence and survival after in-hospital cardiopulmonary cerebral resuscitation in end-stage kidney disease patients: A nationwide population-based study.

机构信息

Department of Cardiology, New Taipei Municipal TuCheng Hospital, Chang Gung Memorial Hospital and Chang Gung University.

Kidney Research Center, Department of Nephrology, Chang Gung Memorial Hospital, Linkou Medical Center, Taoyuan, Taiwan.

出版信息

PLoS One. 2020 Aug 28;15(8):e0238029. doi: 10.1371/journal.pone.0238029. eCollection 2020.

Abstract

BACKGROUND

This study analyzed the survival and protective predictors of in-hospital cardiopulmonary cerebral resuscitation (CPCR) to potentially help physicians create effective treatment plans for End-stage kidney disease (ESKD) patients.

METHODS

We extracted the data of 7,116 ESKD patients who received their first in-hospital CPCR after initial dialysis between 2004 and 2012 from the National Health Insurance Research Database. The primary outcome was the survival rate during the first in-hospital CPCR. The secondary outcome was the median post-discharge survival.

RESULTS

From 2004 through 2012, the incidence of in-hospital CPCR decreases from 3.97 to 3.67 events per 1,000 admission days (P for linear trend <0.001). The survival rate for the first in-hospital CPCR did not change significantly across the 9 years (P for trend = 0.244), whereas the median survival of post-discharge survival increased significantly from 3.0 months in 2004 to 6.8 months in 2011 (P for linear trend <0.001). In addition, multivariable analysis identified older age as a risk factor and prior intracardiac defibrillator (ICD) or cardiac resynchronization therapy defibrillator (CRT-D) implantation as a protective factor for in-hospital death during the first in-hospital CPCR.

CONCLUSION

The incidence of in-hospital CPCR and the duration post-discharge among ESKD patients improved despite there being no significant difference in the survival rate of ESKD patients after CPCP. Either ICD or CRT-D implantation may be advisable for ESKD patients with a high risk of sudden cardiac death.

摘要

背景

本研究分析了院内心肺复苏(CPCR)的生存和保护预测因素,以期帮助医生为终末期肾病(ESKD)患者制定有效的治疗计划。

方法

我们从国家健康保险研究数据库中提取了 2004 年至 2012 年间首次接受初始透析后院内首次 CPCR 的 7116 名 ESKD 患者的数据。主要结局是首次院内 CPCR 期间的生存率。次要结局是出院后中位生存时间。

结果

2004 年至 2012 年,院内 CPCR 的发生率从每 1000 个入院日 3.97 例降至 3.67 例(P 趋势<0.001)。9 年间首次院内 CPCR 的生存率无显著变化(趋势 P=0.244),而出院后中位生存时间从 2004 年的 3.0 个月显著增加到 2011 年的 6.8 个月(线性趋势 P<0.001)。此外,多变量分析确定年龄较大是院内死亡的危险因素,而先前植入心脏内除颤器(ICD)或心脏再同步治疗除颤器(CRT-D)是院内 CPCR 期间院内死亡的保护因素。

结论

尽管 ESKD 患者 CPCR 后生存率无显著差异,但 ESKD 患者院内 CPCR 的发生率和出院后持续时间有所改善。对于有突发心脏死亡高风险的 ESKD 患者,植入 ICD 或 CRT-D 可能是明智的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d0f/7454972/093c1f092185/pone.0238029.g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验